In line with these results, we observed that also overexpression of BTKC481S, a mutation resulting in loss of BTKi binding recurrently found in patients with acquired BTKi resistance, overcomes BTKi sensitivity without affecting KIN-8194 potency in MCL cells (Fig. 5B) [22]. Here, IBTK is linked to mantle cell lymphoma.